Long-term treatment outcomes with lisdexamfetamine dimesylate for adults with attention-deficit/hyperactivity disorder stratified by baseline severity.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To examine the impact of baseline severity on lisdexamfetamine dimesylate (LDX) efficacy
in a long-term study of adults with attention-deficit/hyperactivity disorder (ADHD).